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Genetically Modified Vaccine Types
Vector-based. Inserted antigens for subunit vaccination
• Viral: Poxvirus, adenoviruses and herpes virus
• Bacterial: Salmonella, Listeria, Shigella (research)
Modified Live attenuated vaccines (viruses, bacteria, protozoa)
Using the modified organism as vaccine directly by deleting or 
slowing expression of virulence factors
• Bacteria: Streptococcus, Escherichia, Salmonella
• Virus: Rabies, ILTV, PRRS, BVD
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5Veterinary GM Vaccines (Vectored) – and Status Tawira et al. 2020 
6Gene Edited Vaccines (Vectored) on Market           (Source: Company Homepages)
Vaccine Company Molecular details Indication Development status
Raboral V-RG Merial
LAV. Oral Live vaccinia virus expressing Rabies 
antigen
Rabies
Innovax®-ND-IBD MSD Animal 
Health
LAV. Recombinant Turkey Herpesvirus 
(Marek’s), with antigens from Newcastle 
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LAV. CP7_E2alfs. The main immunogen of CSF 
virus “Alfort/187”, glycoprotein E2, in a 
bovine viral diarrhea virus type 1 backbone
Classical swine fever Marketed
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Modified Live Vaccines on Market                          (European Medicines Agency)
Vaccine Company Molecular details Indication Development status
Hiprabovis IBR 
Marker Live







Live streptococcus strain, aroA deletion





























Abortions, still birth 





Genetically Modified Vaccine Types
Ramezanpour et al. Vaccine. 2016
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GM Vaccines for Humans
• The first: IMO-JEV, Japanese Encephalitis vaccine based on 
yellow fever vector. 2010 Japan.
• The second: Dengvaxia, Japanese encephalitis vaccine, two 
genes from JEV inserted in yellow fever backbone. 2015, many 
countries, Europe, USA
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Liver-stage antigens has been targeted
Timed genome editing
Gene editing for increased immunity
Self destructive parasites
Malaria Research
M.C. Lee, et al. 




Deletion of genes for flagellum attachment (cruzei)
Chagas disese Research
Reviewed by
Yoagubat et al. Trends 
in Parasitol 2020
Protozoa Trypanosoma brucei (humans) Sleeping sickness Research
Reviewed by
Yoagubat et al. Trends 
in Parasitol 2020
Protozoa Trypanosoma vivax (animals) Trypanosomiasis Research
D ’Archivo et al. Plos
Negl Trop Dis. 2011
Protozoa
(Apicomplexan)
Toxoplasma gondii (human and animals) Toxoplasmosis




Crytosporidium spp (human and animals) Cryptosporidiosis
Research
Beverley. Nature  2015
Protozoa Babesia bovis (animals) Babesiosis
Research Asada et al. Mol 
Biochem Parasitol
2012
11Gene Editing of Pathogens at ILRI 
for Vaccines and Research
African Swine Fever (ASF)
• Caused by a large DNA virus
• Present in about 26 countries in Africa – constraint 
to the pig farming
• Major problem in Eastern Europe, Russia and Asia.
Contagious Bovine Pleuropneumonia (CBPP)
• Caused by a Mycoplasma
• One of the most serious cattle diseases in Africa.
• Imposes an estimated minimal cost of > 100 M €/year 






CRISPR Modification of African Swine Fever
Virus backbone: genotype IX isolate from outbreak in Kenya at the 
Ugandan border     Onzere et al., Virus Genes. 2018 
10 different  viruses produced, ready for test in animals
Modify fragments of ASFV
Assemble genomes in yeast
Reconstitute live virus
Test infectivity and growth in
tissue culture and in vivo







Cut out and ligate loops loopsTransform
YCpBac















Mmc – genome transplantation – model 
Schieck et al. Mol Microbiol 2016,     Jores et al. JID 2018  
GM12 YCPMmyc1.1 Δglf
GM12 YCPMmyc1.1
Attenuation of Mycoplasma via Knock-out of Genes Involved in 
Polysaccharide Biosynthesis 
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What Is the Next? 
• Refinement of technologies
- Inducible systems, self-destruction
• DNA plasmid-coded attenuated viruses 
- Optimizing delivery
• Bacterial vectors: Lots of ongoing clinical 
trials 
• Multivalent vaccines:  
Many pathogens in one
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